Free Trial

Semler Scientific (SMLR) Competitors

Semler Scientific logo
$45.97 +3.65 (+8.62%)
Closing price 07/10/2025 04:00 PM Eastern
Extended Trading
$47.32 +1.35 (+2.94%)
As of 04:46 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SMLR vs. CNMD, AORT, CDRE, TNDM, ESTA, LQDA, SSII, FNA, BLFS, and PLSE

Should you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include CONMED (CNMD), Artivion (AORT), Cadre (CDRE), Tandem Diabetes Care (TNDM), Establishment Labs (ESTA), Liquidia Technologies (LQDA), SS Innovations International (SSII), Paragon 28 (FNA), BioLife Solutions (BLFS), and Pulse Biosciences (PLSE). These companies are all part of the "medical equipment" industry.

Semler Scientific vs. Its Competitors

Semler Scientific (NASDAQ:SMLR) and CONMED (NYSE:CNMD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.

CONMED has a net margin of 9.02% compared to Semler Scientific's net margin of -60.69%. Semler Scientific's return on equity of 19.75% beat CONMED's return on equity.

Company Net Margins Return on Equity Return on Assets
Semler Scientific-60.69% 19.75% 15.47%
CONMED 9.02%14.36%5.86%

Semler Scientific presently has a consensus price target of $89.00, indicating a potential upside of 93.60%. CONMED has a consensus price target of $62.20, indicating a potential upside of 16.11%. Given Semler Scientific's stronger consensus rating and higher possible upside, equities research analysts plainly believe Semler Scientific is more favorable than CONMED.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Semler Scientific
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33
CONMED
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.20

49.4% of Semler Scientific shares are owned by institutional investors. 30.2% of Semler Scientific shares are owned by company insiders. Comparatively, 3.1% of CONMED shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

CONMED has higher revenue and earnings than Semler Scientific. Semler Scientific is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Semler Scientific$56.29M11.18$40.90M-$2.61-17.61
CONMED$1.31B1.27$132.42M$3.8014.10

In the previous week, Semler Scientific had 9 more articles in the media than CONMED. MarketBeat recorded 16 mentions for Semler Scientific and 7 mentions for CONMED. CONMED's average media sentiment score of 0.91 beat Semler Scientific's score of 0.27 indicating that CONMED is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Semler Scientific
2 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
CONMED
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Semler Scientific has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Comparatively, CONMED has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500.

Summary

Semler Scientific beats CONMED on 11 of the 17 factors compared between the two stocks.

Get Semler Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SMLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMLR vs. The Competition

MetricSemler ScientificMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$579.29M$6.75B$5.55B$9.04B
Dividend YieldN/A1.26%5.25%4.04%
P/E Ratio-17.6125.5427.2020.14
Price / Sales11.1870.83413.3398.20
Price / Cash9.4620.8037.5058.41
Price / Book1.854.778.085.60
Net Income$40.90M$174.76M$3.16B$248.43M
7 Day Performance15.79%1.56%4.68%5.47%
1 Month Performance44.92%-0.05%4.49%7.87%
1 Year Performance36.73%10.46%30.99%18.75%

Semler Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMLR
Semler Scientific
2.4257 of 5 stars
$45.97
+8.6%
$89.00
+93.6%
+41.9%$579.29M$56.29M-17.61120Analyst Forecast
High Trading Volume
CNMD
CONMED
4.7046 of 5 stars
$52.10
-0.1%
$62.20
+19.4%
-17.9%$1.61B$1.31B13.713,900
AORT
Artivion
2.7067 of 5 stars
$31.17
-0.1%
$32.00
+2.7%
+25.2%$1.33B$388.54M-62.341,600
CDRE
Cadre
3.2734 of 5 stars
$31.94
-0.3%
$37.50
+17.4%
-6.6%$1.30B$567.56M33.622,284
TNDM
Tandem Diabetes Care
4.1754 of 5 stars
$18.64
-1.6%
$33.43
+79.3%
-63.5%$1.26B$940.20M-6.712,650Positive News
Analyst Forecast
ESTA
Establishment Labs
1.6316 of 5 stars
$42.71
+4.3%
$52.40
+22.7%
+6.1%$1.18B$166.02M-13.781,018Analyst Forecast
LQDA
Liquidia Technologies
3.2628 of 5 stars
$12.46
-4.9%
$26.89
+115.8%
+13.2%$1.12B$14M-7.8950
SSII
SS Innovations International
N/A$5.89
+2.1%
N/AN/A$1.12B$20.65M0.004News Coverage
FNA
Paragon 28
N/A$13.11
+0.1%
$12.75
-2.7%
+92.9%$1.10B$256.18M-17.71343,000High Trading Volume
BLFS
BioLife Solutions
2.9128 of 5 stars
$21.54
+0.2%
$31.17
+44.7%
+17.7%$1.02B$82.25M-74.27440High Trading Volume
PLSE
Pulse Biosciences
3.8984 of 5 stars
$15.09
+0.1%
N/A+15.2%$1.01B$700K0.00140

Related Companies and Tools


This page (NASDAQ:SMLR) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners